A. Valetto et al., Use of molecular techniques to confirm true re-emergence of an original clone and to track minimal residual disease in acute lymphoblastic leukemia, HAEMATOLOG, 85(10), 2000, pp. 1102-1103
We report the case of a young girl whose acute lymphoblastic leukemia (ALL)
recurred as lymphoblastic lymphoma 6.6 years after diagnosis. Analysis of
minimal residual disease (MRD) allowed tracking of the leukemic clone durin
g the phases of therapy, confirming that relapse was a true re-emergence of
the original clone.